Casascp 1000 ubr

WO2020232366A2 - Regulated synthetic gene expression systems

Por um escritor misterioso
Last updated 01 novembro 2024
WO2020232366A2 - Regulated synthetic gene expression systems
International application publshed with declaration under Article 17 (2) (a)
WO2020232366A2 - Regulated synthetic gene expression systems
A new control system for synthetic genes, MIT News
WO2020232366A2 - Regulated synthetic gene expression systems
WO2015188191A1 - Dna recombinase circuits for logical control of gene expression - Google Patents
WO2020232366A2 - Regulated synthetic gene expression systems
WO2020232366A2 - Regulated synthetic gene expression systems - Google Patents
WO2020232366A2 - Regulated synthetic gene expression systems
Dynamic Control of Gene Expression with Riboregulated Switchable Feedback Promoters
WO2020232366A2 - Regulated synthetic gene expression systems
The schematics of the site-specific integration process by which the
WO2020232366A2 - Regulated synthetic gene expression systems
Cell-free gene-regulatory network engineering with synthetic transcription factors
WO2020232366A2 - Regulated synthetic gene expression systems
Synthetic biology and bioelectrochemical tools for electrogenetic system engineering
WO2020232366A2 - Regulated synthetic gene expression systems
Gene Expression CK-12 Foundation
WO2020232366A2 - Regulated synthetic gene expression systems
WO2020232366A2 - Regulated synthetic gene expression systems - Google Patents
WO2020232366A2 - Regulated synthetic gene expression systems
WO2020232366A2 - Regulated synthetic gene expression systems - Google Patents
WO2020232366A2 - Regulated synthetic gene expression systems
WO2020232366A2 - Regulated synthetic gene expression systems - Google Patents
WO2020232366A2 - Regulated synthetic gene expression systems
Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation
Recomendado para você
você pode gostar

© 2014-2024 remont-grk.ru. All rights reserved.